Hep Email Update Hepatitis C Survey Tell us about your experience with hepatitis C. As Interest From Families Wanes, Pediatricians Scale Back on COVID Shots Providers don’t want to waste money ordering doses that won’t be used, but they need enough on hand to vaccinate vulnerable children. FDA Approves Nasal Spray Influenza Vaccine for Self or Caregiver Administration FluMist is the first influenza vaccine does not need to be administered by a health care provider. Advertisement Vance Rewrites History About Trump and Obamacare Most of the Trump administration’s ACA-related actions involved cutting the program and backing efforts to overturn the law. Closing the Hepatitis C Treatment Gap Here’s why so few Americans have been cured of hep C—and how we can do better. How to Get Hepatitis C Treatment Tips for people with hep C and for providers. Advertisement Science News FDA Approves and Authorizes Updated COVID-19 Vaccines Immunotherapy Before Surgery May Improve Outcomes for Patients With Liver Cancer Seladelpar Gets Accelerated Approval for Autoimmune Liver Disease NIAID Research to Eliminate the Threat of Viral Hepatitis Across the Globe Newsfeed FDA Approves Nasal Spray Influenza Vaccine for Self or Caregiver Administration Liver Cancer Screening Improved Survival for Adults Cured of Hep C Biden-Harris Administration Issues Proposed Rule to Expand Access to Life-Saving Organs for People with HIV Viral Hepatitis Remains Difficult to Control Worldwide Science News FDA Approves and Authorizes Updated COVID-19 Vaccines Immunotherapy Before Surgery May Improve Outcomes for Patients With Liver Cancer Seladelpar Gets Accelerated Approval for Autoimmune Liver Disease NIAID Research to Eliminate the Threat of Viral Hepatitis Across the Globe Newsfeed FDA Approves Nasal Spray Influenza Vaccine for Self or Caregiver Administration Liver Cancer Screening Improved Survival for Adults Cured of Hep C Biden-Harris Administration Issues Proposed Rule to Expand Access to Life-Saving Organs for People with HIV Viral Hepatitis Remains Difficult to Control Worldwide

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: